Skip to content
compulsory patent licensing india

BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

BioSpectrum Asia – Debate over compulsory licensing of Bayer’s Nexavar  Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO… 

International Bar Association – Patent Enforcement in India

Asia Pacific – Regional Forum News – Newsletter of the International Bar Association Legal Practice Division Full Copy of Publication: Local working requirements and enforceability of patents: an Indian perspective of challenges and opportunities surrounding a… 

patent filing in india

Global Legal Post – Indian Patent Office Backlog

Global Legal Post Publication Before US visit, PM Modi announced to resolve one the most crucial issues daunting the Indian Patent Office, i.e. clearing the huge backlog. Originally published here. Full Article: 1,000 backlog beaters for… 

pharma patent attorney

Swissinfo – Novartis Patent Case – Indacaterol – Onbrez Delhi High Court Judgement

Swissinfo is Swiss Government’s International Publication Service managed by Swiss Broadcasting Corporation (SBC). Originally published here. Views on Delhi High Court’s ruling in Novartis patent dispute: “The ruling is totally in line with existing laws,… 

pharma patent attorney

Pharmaceutical Patents in India – Compulsory Licensing, Health Emergency & Affordable Healthcare – Patent Laws in India

India is facing tremendous pressure from US for enforcement of Intellectual Property Rights (IPR) since last few months, specifically with regards to concerns over violations of pharmaceutical patents in India. Originally published here. Recent Issue…